Navigation Links
CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
Date:1/19/2008

ATLANTA, Jan. 20 /PRNewswire/ -- CeloNova BioSciences, Inc. ("CeloNova"), leading and accelerating healthcare solutions through the provision and development of innovative medical devices, has released data from THE SPHERE, an 11 center, 8 country European study of uterine fibroid embolization using the Company's Embozene(TM) Microspheres. The study results were reported at the 20th Annual International Symposium on Endovascular Therapy.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080120/CLSU001 )

Patients in the study were followed for six months. According to one of the Principal Investigators, Joachim Kettenbach, MD, Medical University of Vienna, "Technical success was achieved in 98% of the patients. The side- effects of fibroids such as pain and heavy menstrual bleeding were significantly reduced while the patients' quality of life improved substantially."

Embolization is a minimally invasive procedure for uterine fibroids during which an Interventional Radiologist injects microspheres through a tiny catheter to the site of the fibroid. The microspheres -- each about the size of a period at the end of this sentence -- block the blood flow to the fibroids causing them to atrophy. The procedure is an alternative for most women with fibroids to surgical procedures such as hysterectomy or myomectomy. Recovery time is measured in days rather than weeks.

CeloNova's Embozene(TM) Color-Advanced Microspheres are the only microspheres that are color-coded by size. They have a hydrogel center and an outer layer of the Company's proprietary coating, Polyzene(R)-F which enhances biocompatibility.

"From the beginning, CeloNova has operated on the principle that our products would give first-rate clinical outcomes for patients and meet the real-world needs of physicians," said Thomas A. Gordy, President and Chief Executive Officer. Gordy continued, "Thi
'/>"/>

SOURCE CeloNova BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
3. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
4. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
5. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
6. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
7. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
8. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
9. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 3, 2015  Cipla, a global pharmaceutical company which ... of all patients, today announced that its UK arm, ... two US-based companies, InvaGen Pharmaceuticals Inc., and Exelan Pharmaceuticals ... is valued at $550 million and will be an ... is over $200 million for the year ended Dec ...
(Date:9/3/2015)... 3, 2015 Report Details ... Drugs, Industry Changes and Emerging Opportunities What,s the ... Visiongain,s new study forecasts those pharmaceutical revenues. There ... industry. You also explore trends, results, treatments, R&D, ... gives revenue predictions to 2025 at overall world ...
(Date:9/3/2015)... -- Report Details What can be expected ... to grow at the fastest rates? Visiongain,s brand new ... trends, opportunities and prospects there. Our 205-page ... most lucrative areas in the industry and the future ... sales at overall world market and regional level. You ...
Breaking Medicine Technology:Cipla to acquire 100% of generic businesses in US for $550M 2Cipla to acquire 100% of generic businesses in US for $550M 3Cipla to acquire 100% of generic businesses in US for $550M 4Cipla to acquire 100% of generic businesses in US for $550M 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 4Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 6Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4
... Inc. (NASDAQ: MSON ), a medical ... therapeutic ultrasonic products worldwide for wound debridement, spinal ... surgical and medical applications, has announced its immediate ... SonicOne® technology to the BoneScalpel™ surgical platform.  The ...
... Simbionix USA Corporation, the world,s leading ... medical professionals and the healthcare industry, is pleased to ... UK for its innovative PROcedure Rehearsal Studio ™ . ... a first in industry product, allowing clinicians to create patient ...
Cached Medicine Technology:Misonix Announces Entry Into Surgical Wound Debridement 2Misonix Announces Entry Into Surgical Wound Debridement 3Patent Granted for Simbionix Procedure Rehearsal Studio™ 2
(Date:9/4/2015)... ... 04, 2015 , ... Steven Winter Associates, Inc., (SWA) is ... selected for the Residential Award of Merit by the Connecticut Green Building Council ... a highly competitive field of submissions, the net-zero energy residence will be honored ...
(Date:9/4/2015)... ... September 04, 2015 , ... Compliance officers deal with ... the Stark physician self-referral law. “Stark Law DOs and DON’Ts: Best Practices ... Services, Inc. (AIS), will detail which deals are attracting the most government scrutiny ...
(Date:9/4/2015)... Texas (PRWEB) , ... September 04, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at ... he says are prophetic details involving the Pope’s upcoming trip to the United States. , ... details what his role with the Vatican and society is. Yisrayl also provides the meaning ...
(Date:9/4/2015)... Charlotte, NC (PRWEB) , ... September 04, 2015 ... ... water filtration products, has a Labor Day offer that cannot be passed up. ... to stock up on necessary air and water filtration product replacements. Take advantage ...
(Date:9/4/2015)... ... September 04, 2015 , ... EMED Jamaica Global ... that it has entered into a multi-year agreement with Health City Cayman Islands. ... the link between American healthcare, Jamaican healthcare and Health City Cayman Islands to ...
Breaking Medicine News(10 mins):Health News:South Glastonbury Home Selected for Award by Connecticut Green Building Council 2Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 4Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 5Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 6
... NEW ORLEANS, La.Using noninvasive molecular imaging technology, a method ... of mesenchymal stem cells (MSCs) in the tumors of ... Meeting. This ability could lead to major advances in ... , "Stem cell cancer therapies are still in the ...
... Resveratrol, a compound present in grapes and red wine, reduces ... used to treat or prevent obesity, according to a new ... 90th Annual Meeting in San Francisco. , Past research ... high-calorie diet from the health problems of obesity, by mimicking ...
... a New Jersey Hospital, RIDGEWOOD, N.J., June 16 ... pledged an historic charitable contribution to The Valley Hospital in,Ridgewood, ... the evolution,of its main campus, is thought to be the ... made this gift to Valley because I want my giving ...
... YORK, June 16, 2008 Researchers at Ben-Gurion University ... new hand gesture recognition system, tested at a Washington, ... during medical procedures by motioning instead of touching a ... spread infection, according to a just released article. , ...
... customer satisfaction and driving new business opportunities., SAN ... 2008, Microsoft Corp. will showcase new ... industry, such as the following:, o ... Applications (OBAs) ...
... (BioMedical Enterprises,Inc.), a privately held medical device company ... announced the launch of the Barbed,OSStaple(TM) (BOSS), a ... The BOSS is an orthopaedic nitinol implant with ... BME OSStaple(TM) product line, the BOSS nitinol,staple changes ...
Cached Medicine News:Health News:Ability to track stem cells in tumors could advance cancer treatments 2Health News:Ability to track stem cells in tumors could advance cancer treatments 3Health News:Red wine's resveratrol may help battle obesity 2Health News:The Valley Hospital in Ridgewood, NJ, Announces Historic $30 Million Gift 2Health News:Gesture interface device developed by Ben-Gurion University of the Negev 2Health News:Microsoft to Showcase Innovative Solutions for Health Plans at AHIP Institute 2008 2Health News:BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the Barbed OSStaple(TM) (BOSS) Nitinol Implant 2
Micro-slide cabinet space saving design, stores as many as 54,000 slides in only two square feet of floor space. Cabinets and base come in 3 colors....
Fisherbrand* Micro Slide Storage Cabinets and Bases (New), available in dark beige, tan, green, or white. Optional bases available with or without legs....
Space-saving storage cabinets for microscope slides....
Seasoned oak cabinet with flat sides and disappearing door...
Medicine Products: